These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28493273)

  • 21. Sexual behavior differences between amphetamine-type stimulants users and heroin users.
    Jia ZJ; Yan SY; Bao YP; Lian Z; Zhang HR; Liu ZM
    J Addict Med; 2013; 7(6):422-7. PubMed ID: 24145161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Why all stimulant drugs are damaging to recreational users: an empirical overview and psychobiological explanation.
    Parrott AC
    Hum Psychopharmacol; 2015 Jul; 30(4):213-24. PubMed ID: 26216554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration.
    Teter CJ; McCabe SE; LaGrange K; Cranford JA; Boyd CJ
    Pharmacotherapy; 2006 Oct; 26(10):1501-10. PubMed ID: 16999660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does chronic use of amphetamine-type stimulants impair interference control? - A meta-analysis.
    Opitz A; Petasch MS; Klappauf R; Kirschgens J; Hinz J; Dittmann L; Dathe AS; Quednow BB; Beste C; Stock AK
    Neurosci Biobehav Rev; 2023 Mar; 146():105020. PubMed ID: 36581170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The epidemiology of methamphetamine use and harm in Australia.
    Degenhardt L; Roxburgh A; Black E; Bruno R; Campbell G; Kinner S; Fetherston J
    Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender differences in abusers of amphetamine-type stimulants and ketamine in southwestern China.
    Zhang Y; Lu C; Zhang J; Hu L; Song H; Li J; Kang L
    Addict Behav; 2013 Jan; 38(1):1424-30. PubMed ID: 23006246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute toxic effects related to 4-fluoroamphetamine.
    Wijers CH; van Litsenburg RT; Hondebrink L; Niesink RJ; Croes EA
    Lancet; 2017 Feb; 389(10069):600. PubMed ID: 28195054
    [No Abstract]   [Full Text] [Related]  

  • 29. Using life course charts to assess and compare trajectories of amphetamine type stimulant consumption in different user groups: a cross-sectional study.
    Martens MS; Zurhold H; Rosenkranz M; O'Donnell A; Addison M; Spencer L; McGovern W; Gabrhelík R; Petruželka B; Rowicka M; Liebregts N; Degkwitz P; Kaner E; Verthein U
    Harm Reduct J; 2020 Jan; 17(1):8. PubMed ID: 31931819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature.
    Wilens TE; Adler LA; Adams J; Sgambati S; Rotrosen J; Sawtelle R; Utzinger L; Fusillo S
    J Am Acad Child Adolesc Psychiatry; 2008 Jan; 47(1):21-31. PubMed ID: 18174822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use trajectories of amphetamine-type stimulants (ATS) in Shanghai, China.
    Du J; Sun H; Huang D; Jiang H; Zhong N; Xu D; Zhao Y; Lin S; Wang W; Du Z; Zhao M; Hser YI
    Drug Alcohol Depend; 2014 Oct; 143():44-50. PubMed ID: 25081602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatalities, Cerebral Hemorrhage, and Severe Cardiovascular Toxicity After Exposure to the New Psychoactive Substance 4-Fluoroamphetamine: A Prospective Cohort Study.
    Hondebrink L; Nugteren-van Lonkhuyzen JJ; Rietjens SJ; Brunt TM; Venhuis B; Soerdjbalie-Maikoe V; Smink BE; van Riel AJHP; de Vries I
    Ann Emerg Med; 2018 Mar; 71(3):294-305. PubMed ID: 28969928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current data on methamphetamine].
    Cottencin O; Rolland B; Guardia D; Karila L
    Rev Prat; 2012 May; 62(5):679-81. PubMed ID: 22730802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An LC-MS/MS methodological approach to the analysis of hair for amphetamine-type-stimulant (ATS) drugs, including selected synthetic cathinones and piperazines.
    Lendoiro E; Jiménez-Morigosa C; Cruz A; Páramo M; López-Rivadulla M; de Castro A
    Drug Test Anal; 2017 Jan; 9(1):96-105. PubMed ID: 26914712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992-2007.
    Maxwell JC; Rutkowski BA
    Drug Alcohol Rev; 2008 May; 27(3):229-35. PubMed ID: 18368603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of illicit use and abuse of prescription stimulants, alcohol, and other drugs among college students: relationship with age at initiation of prescription stimulants.
    Kaloyanides KB; McCabe SE; Cranford JA; Teter CJ
    Pharmacotherapy; 2007 May; 27(5):666-74. PubMed ID: 17461701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Driving under the influence among frequent ecstasy consumers in Australia: trends over time and the role of risk perceptions.
    Matthews AJ; Bruno R; Dietze P; Butler K; Burns L
    Drug Alcohol Depend; 2014 Nov; 144():218-24. PubMed ID: 25282306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tooth surface loss: does recreational drug use contribute?
    Nixon PJ; Youngson CC; Beese A
    Clin Oral Investig; 2002 Jun; 6(2):128-30. PubMed ID: 12166714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smokable ("ice", "crystal meth") and non smokable amphetamine-type stimulants: clinical pharmacological and epidemiological issues, with special reference to the UK.
    Schifano F; Corkery JM; Cuffolo G
    Ann Ist Super Sanita; 2007; 43(1):110-5. PubMed ID: 17536161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Captagon: use and trade in the Middle East.
    Al-Imam A; Santacroce R; Roman-Urrestarazu A; Chilcott R; Bersani G; Martinotti G; Corazza O
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 27766667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.